CCL22 and atopic eczema: In recent studies, increased levels of CC-chemokines, such as thymus, activation-regulated chemokine (TARC/CCL17), and CC-chemokine macrophage-derived chemokine (MDC/CCL22) were observed in the skin of patients with chronic skin inflammatory diseases, including atopic dermatitis.